Lead Megaphone has joined forces with Top of Funnel. Same founder, expanded team, same mission. Visit Top of Funnel →
6 min read

22 New Pharma Factories Are Breaking Ground in the US -- Here Is How Small Manufacturers Get on the Bid List

Most small shop owners are heads-down on diesel, tariffs, and the Hormuz disruption. That is understandable. But while everyone is looking down, the biggest domestic manufacturing demand wave in 40 years is being announced on top of them.

Since February 2026, 13 pharmaceutical companies have publicly committed more than 480 billion dollars to build new US manufacturing capacity. That is 22 new manufacturing sites. Roughly 44,000 new jobs. Johnson and Johnson alone pledged 55 billion. Think Global Health is tracking the full list.

Stack that on top of the Stellantis 13 billion auto reshoring, the GlobalFoundries 16 billion chip reshoring, and the Amkor 7 billion Arizona semiconductor packaging plant, and you are looking at the busiest industrial construction pipeline since the 1960s.

Why This Matters If You Run a Small Shop

Every one of those 22 new sites is going to need suppliers. Tool and die work. Fabrication. Stainless steel work. Cleanroom fixturing. Packaging equipment. HVAC components. Automation integration. Facility maintenance. Freight.

Procurement teams at pharma companies do not buy all of that from national accounts. They buy a significant portion of it from regional suppliers inside a 300-mile service radius of each plant. Travel time matters. Warranty response time matters. Being able to drive to the site on short notice matters.

If your shop is within 300 miles of any of the 22 announced sites, a once-in-a-generation contract pipeline is forming within your service area right now.

The Window Is Already Open

Most shop owners assume these contracts get awarded when the building is done. That is backwards. The bid lists for long-lead-time suppliers are being built during site selection and engineering, not after ribbon cutting.

The EPC firms -- the engineering, procurement, and construction contractors running these builds -- are taking qualification calls right now. Names like Fluor, Jacobs, Bechtel, DPR, Gray, IPS, and Turner are scoping subcontractor and equipment supplier packages in Q2 and Q3 2026 for plants that will not produce their first pill until 2028 or 2029.

The shops that land on the bid list in the next 90 days will still be quoting work on these plants in 2030. The shops that wait until the building is standing will find the pipeline already full.

What Actually Gets You on the List

Three things, in order.

1. Identify the sites in your radius. Think Global Health's tracker has the current list. Cross-reference with your drive-time radius. A 300-mile radius is a good rule of thumb, though anchor capabilities -- cleanroom experience, specific certifications, FDA-registered processes -- can extend that.

2. Find the EPC firm and the procurement contact. Most pharma sites have a public press release naming the EPC. From there, LinkedIn or a direct call gets you to the procurement or subcontractor qualification team. You are not asking for a contract. You are asking to be on the qualified supplier list.

3. Reach out before your capability is formally requested. The manufacturers winning these contracts are not the best machinists. They are the shops that showed up before the RFQ was published. Cold outreach at this stage is not pushy. It is expected. Procurement teams at EPCs are explicitly trying to build deep qualified supplier lists, and most of them have not heard of your shop yet.

The Other 40% of the Story

While this pipeline is forming, most small manufacturers are not positioned to capitalize on it. The reasons are consistent across every shop we talk to.

Sales capacity is the biggest gap. The owner is already running operations, doing quotes, and handling customer issues. Prospecting calls do not happen because there is no time. By the time the owner looks up, the pharma EPC has already qualified three competitors.

Tracking and follow-up is the second gap. A shop owner gets a name at an EPC, has one call, and then never follows up because the lead gets lost in an inbox. Three months later the project is gone and the shop owner never knew it was even in play.

Positioning is the third gap. The shop's website, LinkedIn, and sales collateral do not speak to pharma work specifically. A procurement manager researching a new supplier lands on a generic “job shop” page and moves on.

What We Recommend This Week

If this opportunity lines up with your capability, the next 90 days matter more than the next 90 months.

Pull the Think Global Health list. Identify sites within your service radius. Name the EPC firm for each one. Find two procurement or subcontractor qualification contacts per firm. Reach out with a clear, specific capability statement. Not a brochure. A specific answer to “what would we hire your shop to do on this site.”

The shops that win these contracts will look back on April 2026 as the month they made the calls. The shops that do not will look back on April 2026 as the month they were too busy putting out diesel and tariff fires to pick up the phone.

At Lead Megaphone we help small and mid-size US manufacturers get in front of buyers like these before the RFQ is formal. If your pipeline is not positioned to catch this wave, that is exactly the problem we solve.

Ready to land a pharma reshoring contract?

Book a 15-minute call and we will show you how to get in front of the EPC firms before the RFQ drops.

Book a Discovery Call